- UHRA Home
- Browsing by Author
Browsing by Author "Schifano, Fabrizio"
Now showing items 1-20 of 243
-
2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol) : A preliminary review
Corkery, John; Schifano, Fabrizio; Ghodse, A. Hamid; Elliott, S.; Corazza, Ornella (2012)2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol) are psychoactive substances, sold primarily over the Internet and in 'head' shops ... -
2023: the best year ever for Future Pharmacology (and even better years to come)
Schifano, Fabrizio (2024-01-02) -
25C-NBOMe: preliminary data on pharmacology, psychoactive effects and toxicity of a new potent hallucinogenic drug
Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan, Flamina; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014-07-03)Introduction. The use of novel psychoactive substances (NPSs) has rapidly increased as well as their online availability. The aim of this paper is to provide a comprehensive review of the nature and the risks associated ... -
4,4’-dimethylaminorex (‘4,4’-DMAR’; ‘Serotoni’) misuse; a web-based study
Loi, Barbara; Zloh, Mire; Antonietta, Maria; Corkery, John; Schifano, Fabrizio (2017-06-28)Background: 4,4′-DMAR (4,4’-dimethylaminorex; ‘Serotoni’) is a potent stimulant drug which has recently been associated with a number of fatalities in Europe. Over the last few years, online communities have emerged as ... -
5,6-Methylenedioxy-2-aminoindane : from laboratory curiosity to 'legal high'
Gallagher, C. T.; Assi, S.; Stair, J. L.; Fergus, S.; Corazza, Ornella; Corkery, John; Schifano, Fabrizio (2012-03-01)The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was ... -
Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review
Schifano, Fabrizio; Chiappini, Stefania; Corkery, John; Guirguis, Amira (2018-04-22)Recently, a range of prescription and over-the-counter drugs have been reportedly used as Novel Psychoactive Substances (NPS), due to their potential for abuse resulting from their high dosage/idiosyncratic methods of ... -
Alprazolam-related deaths in Scotland, 2004-2020
Corkery, John Martin; Guirguis, Amira; Chiappini, Stefania; Martinotti, Giovanni; Schifano, Fabrizio (2022-09-27)Background: The benzodiazepine drug alprazolam, a fast-acting tranquiliser, cannot be prescribed on the National Health Service in the United Kingdom. Illicit alprazolam supply and consumption have increased. Concern about ... -
Anabolic androgenic steroid abuse in the United Kingdom: An update
Mullen, Carrie; Whalley, Benjamin J; Schifano, Fabrizio; Baker, Julien S (2020-05)Anabolic androgenic steroids (AASs) are prescribed for medical conditions related to low testosterone. Abuse of AASs has surged as they become recognised as potent image enhancement drugs. The primary goal of most abusers ... -
Analisi dei report online relativi al potenziale uso errato della benzidamina
Schifano, Fabrizio; Corazza, Ornella; Marchi, Alessandro; di Melchiorre, Giuditta; Sferrazza, Elias; Enea, Aurora; Davey, Z.; Blaszko, Ursula; Deluca, Paolo (2013)Benzydamine/Tantum Rosa is a drug for external use. It is typically available in Europe, without the need of a medical prescription, for the treatment of vaginal inflammatory processes. Between December 2009 and January ... -
Analyzing the Open/Deep Web to Better Understand the New/Novel Psychoactive Substances (NPS) Scenarios: Suggestions from CASSANDRA and NPS.Finder Research Projects
Schifano, Fabrizio (2020-03-04)New/novel psychoactive substances (NPS) are defined as new narcotic/psychotropic drugs which are not controlled by the United Nations' 1961 Narcotic Drugs/1971 Psychotropic Substances conventions, but which may pose a ... -
Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
Schifano, Nicolo; Cappogrosso, Paolo; Boeri, Luca; Fallara, Guiseppe; Chiappini, Stefania; Rewhorn, Matthew; Cakir, Omer Onur; Harvey, Hannah; Castiglione, Fabio; Alnajjar, Hussain; Muneer, Asif; Deho, Frederico; Schifano, Fabrizio; Montorsi, Francesco; Salonia, Andrea (2022-05-05)A limited number of studies have described patients on finasteride showing findings which were consistent with Peyronie’s disease (PD). We aimed to detect a pharmacovigilance signal of possible association between finasteride ... -
Assessing prevalence, knowledge and use of cognitive enhancers among university students in the United Arab Emirates: A quantitative study
Sharif, Safia; Fergus, Suzanne; Guirguis, Amira; Smeeton, Nigel; Schifano, Fabrizio (2022-01-26)BACKGROUND: Cognitive enhancers (CE) are often used to improve memory, alertness and cognitive capacity. These products are commercially and pharmaceutically available. Due to high academic pressure, university students ... -
Assessing the 2004-2018 fentanyl misusing issues reported to an international range of adverse reporting systems
Schifano, Fabrizio; Chiappini, Stephania; Corkery, John; Guirguis, Amira (2019-02-01)Objective: A recent, global, increase in the use of opioids including the prescribing, highly potent, fentanyl has been recorded. Due its current popularity and the potential lethal consequences of its intake, we aimed ... -
Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
Scherbaum, Norbert; Bonnet, Udo; Hafermann, Henning; Schifano, Fabrizio; Bender, Stefan; Grigoleit, Torsten; Kuhn, Jens; Nyhuis, Peter; Preuss, Ulrich W; Reymann, Gerhard; Schneider, Udo; Shibata, Jo; Specka, Michael (2021-04-23)Background: In response to the COVID-19-pandemic, a lockdown was established in the middle of March 2020 by the German Federal Government resulting in drastic reduction of private and professional traveling in and out of ... -
Az elektronikus prevenció lehetőségei az új (szintetikus) drogok használatának megelőzésében : a Rekreációs Drogok Európai Hálózatának (Recreational Drugs European Network) bemutatása
Demetrovics, Zsolt; Mervo, Barbara; Corazza, Ornella; Davey, Zoe; Deluca, Paolo; Drummond, C.; Enea, Aurora; Moskalewicz, Jacek; Di Melchiorre, G.; Di Furia, Lucia; Flesland, Liv; Floridi, Luciano; Iszaj, F.; Scherbaum, Norbert; Siemann, Holger; Skutle, Arvid; Torrens, Marta; Pasinetti, Manuela; Pezzolesi, Cinzia; Pisarska, Agnieszka; Shapiro, Harry; Sferrazza, Elias; van der Kreeft, Peer; Schifano, Fabrizio (2010) -
Benefits and Harms of 'Smart Drugs' (Nootropics) in Healthy Individuals
Schifano, Fabrizio; Catalani, Valeria; Sharif, Safia (Sophia); Napoletano, Flavia; Corkery, John; Arillotta, Davide; Fergus, Suzanne; Vento, Alessandro; Guirguis, Amira (2022-04-02)‘Smart drugs’ (also known as ‘nootropics’ and ‘cognitive enhancers’ [CEs]) are being used by healthy subjects (i.e. students and workers) typically to improve memory, attention, learning, executive functions and vigilance, ... -
Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques
Mullin, Anthony; Scott, Mark; Vaccaro, Giorgia; Floresta, Giuseppe; Arillotta, Davide; Catalani, Valeria; Corkery, John M; Stair, Jacqueline L; Schifano, Fabrizio; Guirguis, Amira (2024-01-12)Introduction: The designer benzodiazepine (DBZD) market continues to expand whilst evading regulatory controls. The widespread adoption of social media by pro-drug use communities encourages positive discussions around ... -
The benzydamine experience: A systematic review of Benzydamine abuse
Chiappini, Stephania; Miuli, Andrea; Mosca, Alessio; Pettorruso, Mauro; Guirguis, Amira; Corkery, John Martin; Martinotti, Giovanni; di Giannantonio, Massimo; Schifano, Fabrizio (2021-01-13)Background: Both prescription and over-the-counter (OTC) drugs recently emerged among novel psychoactive substances (NPS) being reported as ingested for recreational purposes. Among them, benzydamine (BZY), normally ... -
Beyond the Purple Drank. Study of promethazine abuse according to the European Medicines Agency (EMA) Adverse Drug Reactions (ADR) reports.
Chiappini, Stefania; Schifano, Fabrizio; Corkery, John Martin; Guirguis, Amira (2021-01-10)Background: Promethazine is a medicinal product, available on its own or in combination with other ingredients including dextromethorphan, paracetamol, and/or expectorants. Anecdotal reports have however indicated that ... -
The bridge between classical and ‘synthetic’/chemical psychoses: towards a clinical, psychopathological and therapeutic perspective
Orsolini, Laura; Chiappini, Stephania; Papanti, Duccio; De Berardis, Domenico; Corkery, John Martin; Schifano, Fabrizio (2019-11-20)The critical spread and dissemination of novel psychoactive substances (NPS), particularly among the most vulnerable youngsters, may pose a further concern about the psychotic trajectories related to the intake of new ...